- English (USA)
- English (UK)
- English (India)
- English (Canada)
- English (Australia)
- English (South Africa)
- English (Philippines)
- Deutsch
- Español (España)
- Español (México)
- Français
- Italiano
- Nederlands
- Polski
- Português (Portugal)
- Português (Brasil)
- Русский
- Türkçe
- العربية
- Ελληνικά
- Svenska
- Suomi
- עברית
- 日本語
- 한국어
- 简体中文
- 繁體中文
- Bahasa Indonesia
- Bahasa Melayu
- ไทย
- Tiếng Việt
- हिंदी
Quest Diagnostics Incorporated (DGX)
Quest Diagnostics Incorporated stock price live, this page displays NYSE DGX stock exchange data. View the DGX premarket stock price ahead of the market session or assess the after hours quote. Monitor the latest movements within the Quest Diagnostics Incorporated real time stock price chart below.
What Is the Quest Diagnostics Incorporated Stock Price Today?
The Quest Diagnostics Incorporated stock price today is 173.32.
What Is the Stock Symbol for Quest Diagnostics Incorporated?
The stock symbol for Quest Diagnostics Incorporated is ""DGX.""
What Stock Exchange Does Quest Diagnostics Incorporated Trade On?
Quest Diagnostics Incorporated is listed and trades on the NYSE stock exchange.
Is Quest Diagnostics Incorporated a Good Stock to Buy?
Determining whether Quest Diagnostics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DGX quote. (ISIN: US74834L1008)
What Is the Quest Diagnostics Incorporated Stock Price Today?
The Quest Diagnostics Incorporated stock price today is 173.32.
What Is the Stock Symbol for Quest Diagnostics Incorporated?
The stock symbol for Quest Diagnostics Incorporated is ""DGX.""
What Stock Exchange Does Quest Diagnostics Incorporated Trade On?
Quest Diagnostics Incorporated is listed and trades on the NYSE stock exchange.
Is Quest Diagnostics Incorporated a Good Stock to Buy?
Determining whether Quest Diagnostics Incorporated—or any stock—is a good buy requires comprehensive analysis. To evaluate its potential, users can sign up to InvestingPro, where they can assess stock price fair value and other essential metrics.
You can find more details by visiting the additional pages to view historical data, charts, latest news, analysis or visit the forum to view opinions on the DGX quote. (ISIN: US74834L1008)
173.32
+0.88(+0.51%)
Real-time Data·
Fair Value
An estimate of a Quest Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
171.91
173.42
52 wk Range
145.43
182.38
DGX Scorecard
Full Analysis
Has raised its dividend for 13 consecutive years
DGX is included in our AI-picked strategies. See how they work
Review Strategies
Fair Value
An estimate of a Quest Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Day's Range
171.91173.42
52 wk Range
145.43182.38
Key Statistics
Edit
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.86%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
Prev. Close
Open
Volume
Average Volume (3m)
1-Year Change
Book Value / Share
Fair Value
UnlockFair Value Upside
UnlockMarket Cap
Shares Outstanding
Revenue
Net Income
EPS
EPS Growth Forecast
UnlockNext Earnings Date
(1.86%)
Dividends Payment Streak
UnlockP/E Ratio
Return on Assets
Return on Equity
Gross Profit Margin
Price/Book
EBITDA
EV/EBITDA
Beta
DGX Scorecard
Company’s Health
Assesses a company's financial position by analysing its market value, financial ratios, industry benchmarks, and competitors.
UnlockFair Value
An estimate of a Quest Diagnostics's true price based on valuation models like discounted cash flow, peer valuation multiples, and dividend discount models.
Unlock PriceTechnical Analysis
Strong Buy
Price Target
188.19
Upside
+8.58%
Members' Sentiments
Bearish
Bullish
ProTips
Tips that distill complex financial data into concise, actionable investment insights.
7 analysts have revised their earnings downwards for the upcoming period
- Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
- Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro - Quest Diag receives Investment Bank Analyst Rating Update
- Investing.com
Pro
Technical Analysis
Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy
Quest Diagnostics Incorporated Company Profile
Quest Diagnostics Incorporated provides diagnostic testing and services in the United States and internationally. The company develops and delivers diagnostic information services, such as routine, non-routine and advanced clinical testing, anatomic pathology testing, and other diagnostic information services. It also provides diagnostic information services primarily under the Quest Diagnostics brand, as well as under the AmeriPath, Dermpath Diagnostics, ExamOne, and Quanum brands to physicians, hospitals, patients and consumers, health plans, government agencies, employers, emerging retail healthcare providers, pharmaceutical companies and insurers, commercial clinical laboratories, and accountable care organizations through a network of laboratories, patient service centers, phlebotomists in physician offices, call centers and mobile phlebotomists, nurses, and other health and wellness professionals. In addition, the company offers risk assessment services for the life insurance industry; and healthcare organizations and clinicians information technology solutions. Quest Diagnostics Incorporated was founded in 1967 and is headquartered in Secaucus, New Jersey.
Quest Diagnostics Incorporated Earnings Call Summary for Q2/2025
- Quest Diagnostics reported Q2 2025 adjusted EPS of $2.62, beating estimates of $2.57, with revenue of $2.76 billion exceeding forecast of $2.73 billion
- Consolidated revenues increased 15.2% year-over-year, with organic revenue growth at 5.2%; stock rose 3.33% in pre-market trading to $172 per share
- Full-year 2025 revenue guidance set at $10.8-$10.92 billion, with adjusted EPS expected between $9.63-$9.83 and organic revenue growth of 3.5-4%
- Company highlighted new product launches in diagnostics and automation improvements; plans to continue investing in Project Nova and modernization efforts
- Executives addressed potential healthcare policy changes and tariff impacts, noting existing contracts and legislative efforts for PAMA reform as mitigating factors
Last Updated: 22/07/2025, 14:32
Read Full TranscriptCompare DGX to Peers and Sector
Metrics to compare | DGX | Sector Sector - Average of metrics from a broad group of related Healthcare sector companies | Relationship RelationshipDGXPeersSector | |
|---|---|---|---|---|
P/E Ratio | 20.4x | 7.6x | −0.5x | |
PEG Ratio | 1.60 | 0.28 | 0.00 | |
Price/Book | 2.7x | 1.8x | 2.6x | |
Price / LTM Sales | 1.8x | 1.4x | 3.3x | |
Upside (Analyst Target) | 10.2% | 75.2% | 43.5% | |
Fair Value Upside | Unlock | 14.1% | 6.3% | Unlock |
Analyst Ratings
9 Buy
9 Hold
0 Sell
Ratings:
18 analysts
Overall Consensus
Buy
Analysts 12-Month Price Target:
Average 188.19
(+8.58% Upside)
Earnings
Latest Release
Jul 22, 2025
EPS / Forecast
2.62 / 2.57
Revenue / Forecast
2.76B / 2.73B
People Also Watch
FAQ
What Stock Exchange Does Quest Diagnostics Trade On?
Quest Diagnostics is listed and trades on the New York Stock Exchange stock exchange.
What Is the Stock Symbol for Quest Diagnostics?
The stock symbol for Quest Diagnostics is "DGX."
What Is the Quest Diagnostics Market Cap?
As of today, Quest Diagnostics market cap is 19.35B.
What Is Quest Diagnostics's Earnings Per Share (TTM)?
The Quest Diagnostics EPS (TTM) is 8.48.
When Is the Next Quest Diagnostics Earnings Date?
Quest Diagnostics will release its next earnings report on 27 Oct 2025.
From a Technical Analysis Perspective, Is DGX a Buy or Sell?
Based on moving averages and other technical indicators, the daily buy/sell signal is Strong Buy.
How Many Times Has Quest Diagnostics Stock Split?
Quest Diagnostics has split 2 times.
How Many Employees Does Quest Diagnostics Have?
Quest Diagnostics has 50500 employees.
What is the current trading status of Quest Diagnostics (DGX)?
As of 05 Aug 2025, Quest Diagnostics (DGX) is trading at a price of 173.32, with a previous close of 172.44. The stock has fluctuated within a day range of 171.91 to 173.42, while its 52-week range spans from 145.43 to 182.38.
Install Our App
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers
© 2007-2025 - Fusion Media Limited. All Rights Reserved.